STOCK TITAN
  1. Home
  2. PLPRF

Plus Prods Stock Price, News & Analysis

PLPRF OTC

Company Description

Plus Prods (OTC: PLPRF) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $1.8B.

This page provides a comprehensive overview of PLPRF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$1.8B
Market Cap
43.3M
Shares outstanding

Latest News

View All
—

Glass House Brands to Acquire PLUS, a Leading California Edibles Brand

acquisition
—

Plus Products Obtains Extension of Stay Period and Claims Process Order Under the Companies’ Creditors Arrangement Act (Canada)

—

Plus Products Reveals Dual Action Sleep gummies featuring first combined fast acting, long lasting formulation

—

Plus Products Files for Creditor Protection Under the Companies’ Creditors Arrangement Act and Cancels September 14 Annual General Meeting

—

Plus Products Achieves Record Quarterly Sales, Reports Second Quarter 2021 Financial Results

earnings
—

Plus Products Releases Preliminary Unaudited Second Quarter 2021 Revenue, Announces Date for the Release of Second Quarter 2021 Results, Conference Call and Webcast

conferences earnings

Plus Prods has 10 recent news articles. Key topics include acquisition, earnings, conferences, management. View all PLPRF news →

SEC Filings

View All

No SEC filings available for PLPRF.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

Related Stocks

EMBCV EMBCV
1.9B
BCRX Biocryst Pharmaceuticals Inc
2.2B
PAHC Phibro Animal
2.2B
HLUKF H Lundbeck
4.9B
AVDL Avadel Pharmaceu
2.1B
BGM BGM Group
65.8M
HROW Harrow Health Inc
1.4B
AMPH Amphastar Pharma
935.7M

PLPRF Company Profile & Sector Positioning

Plus Prods (PLPRF) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing PLPRF often look at related companies in the same sector, including (EMBCV), Biocryst Pharmaceuticals Inc (BCRX), Phibro Animal (PAHC), H Lundbeck (HLUKF), and Avadel Pharmaceu (AVDL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PLPRF's relative position within its industry.

Frequently Asked Questions

What is the market cap of Plus Prods (PLPRF)?

The market cap of Plus Prods (PLPRF) is approximately 1.8B. Learn more about what market capitalization means .